Bay Colony Advisory Group, Inc D Bristol Myers Squibb CO Transaction History
Bay Colony Advisory Group, Inc D
- $631 Million
- Q1 2025
A detailed history of Bay Colony Advisory Group, Inc D transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bay Colony Advisory Group, Inc D holds 10,432 shares of BMY stock, worth $519,722. This represents 0.1% of its overall portfolio holdings.
Number of Shares
10,432
Previous 10,254
1.74%
Holding current value
$519,722
Previous $579,000
9.84%
% of portfolio
0.1%
Previous 0.09%
Shares
29 transactions
Others Institutions Holding BMY
# of Institutions
2,779Shares Held
1.56BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$9.46 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.9 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$4.78 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$4.74 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $106B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...